GLP-1's effects on gastric emptying, appetite, and food intake were investigated for amylin co-release involvement in humans, finding that GLP-1's actions are largely independent of amylin — separate satiety pathways.
Key findingGLP-1's effects on gastric emptying, appetite, and food intake were investigated for amylin co-release involvement in humans, finding that GLP-1's act
What the researchers found
GLP-1's effects on gastric emptying, appetite, and food intake were investigated for amylin co-release involvement in humans, finding that GLP-1's actions are largely independent of amylin — separate satiety pathways.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?
The Journal of clinical endocrinology and metabolism, 95(5), 2367-75
Citation
Asmar, Meena; Bache, Michael; Knop, Filip K; Madsbad, Sten; Holst, Jens J. (2010). Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?. The Journal of clinical endocrinology and metabolism, 95(5), 2367-75. https://doi.org/10.1210/jc.2009-2133